Sapphire Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 13.50 Cr
as on 26-06-2024
- Paid Up Capital ₹ 13.13 Cr
as on 26-06-2024
- Company Age 34 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 32.95 Cr
as on 26-06-2024
- Satisfied Charges ₹ 7.22 Cr
as on 26-06-2024
- Revenue 70.37%
(FY 2022)
- Profit 235.95%
(FY 2022)
- Ebitda 27.07%
(FY 2022)
- Net Worth 32.66%
(FY 2022)
- Total Assets 49.50%
(FY 2022)
About Sapphire Lifesciences
The Corporate was formerly known as Saphire Capules Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.50 Cr and a paid-up capital of Rs 13.13 Cr.
The company currently has active open charges totaling ₹32.95 Cr. The company has closed loans amounting to ₹7.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sapphire Lifesciences Private Limited India is Afshan Shaikh as COMPANY SECRETARY. Ganesh Baburaya and Parag Shah serve as directors at the Company.
- CIN/LLPIN
U24239MH1990PTC055572
- Company No.
055572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sapphire Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Afshan Shaikh  | Company Secretary | 01-Apr-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parag Shah | Director | 30-Mar-2004 | Current |
| Ganesh Baburaya | Director | 05-Dec-2003 | Current |
Financial Performance and Corporate Structure Insights of Sapphire Lifesciences.
Sapphire Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 70.37% increase. The company also saw a substantial improvement in profitability, with a 235.95% increase in profit. The company's net worth Soared by an impressive increase of 32.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapphire Lifesciences?
In 2022, Sapphire Lifesciences had a promoter holding of 92.03% and a public holding of 7.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 May 2017 | ₹3.00 Cr | Open |
Others Creation Date: 28 Feb 2013 | ₹29.95 Cr | Open |
Others Creation Date: 03 Sep 2020 | ₹8.18 M | Satisfied |
How Many Employees Work at Sapphire Lifesciences?
Unlock and access historical data on people associated with Sapphire Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapphire Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapphire Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
